Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know
Portfolio Pulse from Benzinga Insights
Investors have taken a predominantly bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA) as indicated by recent options trades. Benzinga's options scanner detected 9 trades, with 88% being bearish. The price target for TEVA ranges from $15.0 to $22.0. The stock is currently up 2.14% at $16.95, but RSI indicators suggest it may be overbought. Analysts have a consensus target price of $20.0.
May 22, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Investors have taken a predominantly bearish stance on Teva Pharmaceutical Indus (NYSE:TEVA) as indicated by recent options trades. The stock is currently up 2.14% at $16.95, but RSI indicators suggest it may be overbought. Analysts have a consensus target price of $20.0.
The high volume of bearish options trades suggests that investors expect the stock price to decline. Despite the current price increase, RSI indicators hint at an overbought condition, which could lead to a price correction. Analysts' target price of $20.0 provides some upside potential, but the short-term sentiment is negative.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100